Patients with the rs1323040 AA genotype may have decreased sufentanil dose requirements as compared to patients with the AG or GG genotypes. This drug-variant pair has been assigned a 鈥渘o recommendation鈥?by CPIC, as it was determined to be not clinically actionable. Other genetic and clinical factors may also affect sufentanil dose requirements.